Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY:BSX)

104.44 -0.20 (-0.19%)
Streaming Delayed Price Updated: 12:24 PM EDT, May 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
What Does Boston Scientific's Debt Look Like?
Shares of Boston Scientific (NYSE:BSX) decreased by 6.16% in the past three months. Before having a look at the importance of debt, let us look at how much debt Boston... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021
Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE: 
Via Benzinga
Where Boston Scientific Stands With Analysts
Within the last quarter, Boston Scientific (NYSE:BSX) has ob... 
Via Benzinga
Unusual Options Activity Insight: Boston Scientific
On Tuesday, shares of Boston Scientific (NYSE:BSX) saw unusu... 
Via Benzinga
2 Medical Device Stocks Wall Street Predicts Will Rally 35% Or More
Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices used in a range of interventional medical specialties. 
Via Talk Markets
Ominous Death Cross Forms On Boston Scientific's Chart
If history is any guide, there may be trouble ahead for shares of Boston Scientific (NYSE:BSX). A so-called "death cross" has formed on its chart and, not surprisingly, this... 
Via Benzinga
Boston Scientific Corp (BSX) Q3 2021 Earnings Call Transcript
BSX earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Boston Scientific Q3 Earnings Comes Inline With Wall Street Expectations
Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.93 billion in Q3 of 2021, almost in line with the Wall Street estimate of $2.97 billion. Sales... 
Via Benzinga
Recap: Boston Scientific Q3 Earnings
Boston Scientific (NYSE:BSX) reported its Q3 earnings results on Wednesday, October 27, 2021 at 06:30 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
Boston Scientific's Eluvia Drug-Eluting Vascular Stent Tops Bare Metal Stents
Boston Scientific Corporation (NYSE: BSX) has announced data for the Eluvia Drug-Eluting Vascular Stent System (Eluvia stent) at the Vascular InterVentional... 
Via Benzinga
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc... 
Via Benzinga
Exposures COVID-19
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength... 
Via Benzinga
Exposures Product Safety
Boston Scientific Beefs Up Electrophysiology, Structural Heart Portfolio With $1.75B Baylis Deal
Boston Scientific Corporation (NYSE: BSX) has agreed to acquire Baylis Medical Company Inc for an upfront payment of $1.75 billion. The acquisition will... 
Via Benzinga
Boston Scientific Highlights Trial Data For EkoSonic System For Pulmonary Embolism
Boston Scientific Corporation (NYSE: BSX) announced results for the EkoSonic Endovascular System at the Vascular InterVentional Advances (VIVA) meeting. ... 
Via Benzinga
FDA Takes Note Of Higher Risk For Women With Stroke-Preventing Implants
The FDA informed health care providers of the potential for differences in procedural outcomes between women and men undergoing implant of a left atrial appendage... 
Via Benzinga
Exposures Product Safety
Increasing Incidences of Cardiac Arrhythmias Raising Demand for Electrophysiology Medical Devices
Via FinancialNewsMedia
Boston Scientific Acquires Provider Of Thrombectomy Platform In Over $300M Deal
Boston Scientific Corporation (NYSE: BSX) has agreed to acquire Devoro Medical Inc for over 300 million. Boston Scientific has been a strategic investor in... 
Via Benzinga
Boston Scientific Posts Colorectal Cancer Survival Data For Tumor-Targeting Microbeads
Boston Scientific Corporation (NYSE: BSX) announced that the EPOCH clinical trial of the TheraSphere Y-90 Glass Microspheres (TheraSphere treatment) met both primary... 
Via Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics... 
Via Benzinga
Exposures COVID-19
'Fast Money Halftime Report' Picks For September 15
On CNBC's "Fast Money Halftime Report," Karen Firestone said Charles Schwab (NYSE: SCHW) has a lot of new young traders who have larger accounts than Robinhood... 
Via Benzinga
Abbott Says Amulet Superior To Boston Scientific's Watchman In Stroke Study
Abbott Laboratories (NYSE: ABT) has announced late-breaking data from the Amulet LAA Occluder IDE trial. The head-to-head study compared Abbott's Amplatzer... 
Via Benzinga
Post Market Studies Reinforce Unfavorable Risk-Benefit Profile For Boston Scientific's Vaginal Mesh
Final results from postmarket surveillance studies of Boston Scientific Corporation's (NYSE: BSX) transvaginal mesh for pelvic organ prolapse (POP) have reinforced... 
Via Benzinga
Boston Scientific's Exalt Model B Single-Use Bronchoscope Wins FDA Approval
The FDA has given 510(k) clearance for Boston Scientific Corp's (NYSE: BSX) Exalt Model B single-use bronchoscope for use in bedside procedures within the intensive... 
Via Benzinga
Exposures Product Safety
Boston Scientific Recalls Faulty Pacemakers Due To Risk of Incorrect Transition To Safety Mode
Boston Scientific Corporation (NYSE: BSX) is recalling Ingenio family pacemakers or cardiac resynchronization therapy pacemakers (CRT-Ps) devices due to the risk of... 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Boston Scientific Starts Trial For EkoSonic Endovascular System In Patients With Pulmonary Embolism
Boston Scientific Corporation (NYSE: BSX) began enrollment for a clinical trial of its EkoSonic endovascular system (EKOS). Boston Scientific’s HI-PEITHO... 
Via Benzinga
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
'Fast Money Halftime Report' Picks For July 30
On CNBC's "Fast Money Halftime Report," Shannon Saccocia picked salesforce.com, inc. (NYSE: CRM) as her final trade. The company is going to report earnings in few... 
Via Benzinga
Stock Market Rally Pauses Near Highs Amid Earnings From Apple, Microsoft, Tesla, Amazon, Google, Facebook
The market rally paused on the key indexes amid earnings from Apple, Tesla and Amazon. But several stocks flashed buy signals. 
Via Investor's Business Daily
Topics Economy Stocks
Exposures Interest Rates US Equities
Boston Scientific Corp (BSX) Q2 2021 Earnings Call Transcript
BSX earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.